64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)
NCT05249127
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate
Interventions
DRUG:
64Cu-SAR-bisPSMA
Sponsor
Clarity Pharmaceuticals Ltd